23
Participants
Start Date
February 4, 2020
Primary Completion Date
October 13, 2023
Study Completion Date
October 13, 2023
Itacitinib
Itacitinib administered orally at the specified dose.
UPMC, Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
Temple University Department of Thoracic Medicine and Surgery, Philadelphia
Duke University Health System, Durham
Cleveland Clinic, Cleveland
University of California, Los Angeles - David Geffen School of Medicine, Los Angeles
Brigham and Women'S Faulkner Hospitals Inc, Boston
Universitaire Ziekenhuis Leuven - Gasthuisberg, Leuven
University Health Network Toronto General Hospital, Toronto
Lead Sponsor
Incyte Corporation
INDUSTRY